PHARMACYCLICS, INC.
NASDAQ: PCYC
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
8 years ago
Last Updated: 8 years ago
There were some interesting positions of hedge funds in biotech, long and short, from the Goldman Sachs Hedge Fund Trend Monitor.
8 years ago
Last Updated: 8 years ago
24/7 Wall St. has found four good examples of blue-chip stocks that got a little tarnished recently for one reason or another, that investors may want to reexamine.
8 years ago
Last Updated: 8 years ago
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
8 years ago
Last Updated: 8 years ago
News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.
8 years ago
Last Updated: 8 years ago
Friday's top analyst upgrades, downgrades and initiations include Bank of America, CA, CBOE, CSX, FedEx, ITT and Potbelly.
8 years ago
Last Updated: 8 years ago
Thursday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Coach, Garmin, Intelsat, Potbelly, SolarCity and Valero Energy.
8 years ago
Last Updated: 8 years ago
Source: ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that the...
8 years ago
Last Updated: 3 years ago
A new research report from Baird highlights the firm's top picks for 2015. We screened the Baird list, which is a very diverse and solid group of picks, for the momentum stocks they tout as top picks...
8 years ago
Last Updated: 3 years ago
With the bull market nearing six years old, 24/7 Wall St. has identified 11 large and well-known stocks that are valued at over 50 times earnings.
8 years ago
Last Updated: 8 years ago
SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated stock.
9 years ago
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
9 years ago
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks to buy at...
9 years ago
Last Updated: 3 years ago
Source: ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical...
9 years ago
Source: Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many...
9 years ago